Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Sell
8,738
-502
-5% -$99.7K 0.5% 42
2026
Q1
$1.36M Buy
9,240
+130
+1% +$19K 0.29% 62
2025
Q4
$1.11M Sell
9,110
-420
-4% -$49.3K 0.23% 70
2025
Q3
$1.03M Buy
9,530
+130
+1% +$12.1K 0.22% 69
2025
Q2
$842K Sell
9,400
-220
-2% -$16.6K 0.21% 68
2025
Q1
$654K Buy
9,620
+80
+0.8% +$5.76K 0.18% 76
2024
Q4
$601K Buy
9,540
+1,170
+14% +$79.1K 0.16% 85
2024
Q3
$648K Buy
8,370
+190
+2% +$14.9K 0.18% 79
2024
Q2
$674K Sell
8,180
-220
-3% -$16.3K 0.19% 72
2024
Q1
$587K Sell
8,400
-40
-0.5% -$2.57K 0.15% 86
2023
Q4
$491K Buy
8,440
+2,310
+38% +$120K 0.14% 95
2023
Q3
$281K Buy
+6,130
New +$294K 0.11% 98

Other funds holding KLAC

Crumly & Associates's KLAC Position: Q2 2026 in Review

Crumly & Associates reduced its KLA (KLAC) stake by 5.4% in Q2 2026, selling an estimated $99.7K and leaving 8,738 shares worth $2.64M. The position accounts for 0.5% of the portfolio, ranked #42.

Crumly & Associates first reported a position in KLAC in Q3 2023 and has held it in 12 quarters since. 688 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Crumly & Associates held 8,738 shares of KLA worth $2.64M as of Q2 2026.
  • Crumly & Associates sold 502 KLA shares in Q2 2026, an estimated $99.7K.
  • KLA made up 0.5% of Crumly & Associates's portfolio in Q2 2026, its #42 holding.
  • Crumly & Associates first reported a position in KLA in Q3 2023 and has held it in 12 quarters since.
  • 688 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.